Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Cancer Epidemiol. 2014 Mar 13;38(2):137–143. doi: 10.1016/j.canep.2014.02.006

Table 1.

Descriptive characteristics of HIV-positive and HIV-negative KS cases and controls

KS Cases KS Controls
HIV-positive
N (%)
HIV-negative
N (%)
HIV-positive
N (%)
HIV-negative
N (%)
Total N 161 14 680 322
KSHV seropositivity
 K8.1 positive 154 (95.7) 14 (100.0) 527 (77.5) 241 (74.8)
 Orf 73 positive 145 (90.1) 14 (100.0) 486 (71.5) 214 (66.5)
 Overall positive 158 (98.1) 14 (100.0) 550 (80.9) 257 (79.8)
Proportion Male 91 (56.5) 14 (100.0) 407 (59.9) 188 (58.4)
Age range in years
 19–29 21 (13.0) 2 (14.3) 83 (12.2) 43 (13.4)
 30–39 67 (41.6) 1 (7.1) 276 (40.6) 139 (43.2)
 40–49 45 (28.0) 3 (21.4) 190 (27.9) 82 (25.5)
 ≥50 28 (17.4) 8 (57.1) 131 (19.3) 58 (18.0)
Occupation
 Professional 52 (32.5) 6 (42.9) 232 (34.2) 158 (49.1)
 Semi-skilled 21 (13.1) 0 (0.0) 101 (14.9) 33 (10.2)
 Trader/sales 29 (18.1) 1 (7.1) 172 (25.4) 48 (14.9)
 Farmer 13 (8.1) 4 (28.6) 34 (5.0) 10 (3.1)
 Unemployed 45 (28.1) 3 (21.4) 139 (20.5) 73 (22.7)
Marital status
 Single/Divorced/Widowed 77 (47.8) 4 (28.6) 272 (40.0) 115 (35.7)
 Married 70 (43.5) 9 (64.3) 319 (46.9) 170 (52.8)
 Open relationship 14 (8.7) 1 (7.1) 89 (13.1) 37 (11.5)
Educational Attainment
 None/primary 34 (21.1) 4 (28.6) 155 (22.8) 54 (16.8)
 Secondary 96 (59.6) 6 (42.9) 363 (53.5) 192 (59.6)
 Higher 31 (19.3) 4 (28.6) 161 (23.7) 76 (23.6)
Region of origin
 Littoral 9 (5.7) 1 (7.1) 32 (4.8) 30 (9.4)
 South (South, Center, East) 98 (62.4) 8 (57.1) 358 (53.5) 126 (39.4)
 West (West, NW, SW) 45 (28.7) 5 (35.7) 253 (37.8) 141 (44.1)
 North (North, Adamawa, Extreme North) 5 (3.2) 0 (0.0) 26 (3.9) 23 (7.2)
Ethnic group
 Bantu 108 (67.1) 9 (64.3) 395 (58.1) 161 (50.0)
 Semi-bantu 45 (28.0) 5 (35.7) 255 (37.5) 139 (43.2)
 Other 8 (5.0) 0 (0.0) 30 (4.4) 22 (6.8)

KS = Kaposi’s Sarcoma

HIV = Human Immunodeficiency Virus

N = Number

KSHV = Kaposi’s Sarcoma Herpesvirus

Overall positive = Defined as having a positive test to either or both K8.1 and Orf73 ELISA tests.